| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
47,216 |
45,161 |
$4.38M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
14,892 |
14,530 |
$1.72M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
9,755 |
9,697 |
$1.21M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,054 |
4,759 |
$712K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
30,114 |
29,631 |
$642K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
17,310 |
17,075 |
$499K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,323 |
2,303 |
$287K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,749 |
1,721 |
$183K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,362 |
1,338 |
$181K |
| 99215 |
Prolong outpt/office vis |
842 |
797 |
$153K |
| 90670 |
|
7,484 |
7,397 |
$144K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,847 |
1,779 |
$101K |
| 99460 |
|
651 |
645 |
$73K |
| 96127 |
|
9,960 |
8,207 |
$73K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
825 |
815 |
$70K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,123 |
3,357 |
$60K |
| 99072 |
|
8,579 |
8,266 |
$49K |
| 90723 |
|
5,578 |
5,517 |
$40K |
| 90686 |
|
9,723 |
9,610 |
$34K |
| 90474 |
|
1,745 |
1,724 |
$25K |
| S0281 |
Medical home program, comprehensive care coordination and planning, maintenance of plan |
5,538 |
5,538 |
$23K |
| 90651 |
|
345 |
339 |
$22K |
| 96161 |
|
6,022 |
5,939 |
$20K |
| 99205 |
Prolong outpt/office vis |
76 |
75 |
$20K |
| 90681 |
|
1,789 |
1,768 |
$19K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
534 |
531 |
$18K |
| 90710 |
|
233 |
226 |
$15K |
| 90677 |
|
1,275 |
1,258 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
854 |
821 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
409 |
391 |
$13K |
| 90633 |
|
1,905 |
1,876 |
$11K |
| 85013 |
|
1,539 |
1,466 |
$10K |
| 90648 |
|
8,436 |
8,351 |
$10K |
| 90734 |
|
223 |
219 |
$9K |
| 83655 |
|
742 |
709 |
$9K |
| 90716 |
|
132 |
131 |
$6K |
| 99173 |
|
1,851 |
1,824 |
$6K |
| 90620 |
|
56 |
55 |
$4K |
| 92551 |
|
293 |
292 |
$4K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
160 |
155 |
$3K |
| 90696 |
|
158 |
155 |
$3K |
| S0315 |
Disease management program; initial assessment and initiation of the program |
334 |
334 |
$3K |
| G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) |
34 |
34 |
$2K |
| 96160 |
|
702 |
639 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
508 |
490 |
$2K |
| 90715 |
|
161 |
159 |
$2K |
| 90656 |
|
597 |
593 |
$1K |
| 0002A |
|
34 |
34 |
$1K |
| 90700 |
|
160 |
159 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
61 |
60 |
$1K |
| 96381 |
|
48 |
43 |
$1K |
| 0071A |
|
30 |
30 |
$1K |
| 99417 |
Prolong home eval add 15m |
77 |
59 |
$1K |
| 85014 |
|
453 |
429 |
$1K |
| 90707 |
|
44 |
44 |
$948.08 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
25 |
17 |
$820.97 |
| 0072A |
|
20 |
20 |
$720.00 |
| 0001A |
|
12 |
12 |
$440.00 |
| 90381 |
|
29 |
25 |
$407.88 |
| 81002 |
|
154 |
141 |
$338.08 |
| A4627 |
Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler |
14 |
14 |
$115.86 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
39 |
39 |
$34.90 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
17 |
17 |
$18.64 |
| 99174 |
|
4,807 |
4,777 |
$7.33 |
| 91307 |
|
128 |
123 |
$0.00 |
| 36416 |
|
55 |
39 |
$0.00 |
| 94760 |
|
13 |
13 |
$0.00 |
| 91300 |
|
114 |
109 |
$0.00 |